アブストラクト | OBJECTIVE: To identify which medications are mostly associated with ejaculatory disorders through a disproportionality analysis. METHODS: The Food and Drug Administration Adverse Event Reporting System (FDA-FAERS) and the Eudra-Vigilance (EV) database were queried to identify medications more commonly associated to ejaculatory disorders from September 10, 2012 to June 1, 2023. Proportional Reported Ratios (PRRs) were computed for all the selected drugs. RESULTS: Overall, 7404 reports of ejaculatory disorders reports were identified, and of these, 6854 cases (92.6%) were attributed to ten specific medications. On FDA-FAERS and EV databases, Paroxetine and Tamsulosin were the main responsible of delayed ejaculation (103/448 events, 23.0%) and retrograde ejaculation (366/1033 events, 35.4%), respectively. Finasteride was mostly related to painful ejaculation and ejaculation failure, with 150 events (7.8%) and 735 events (38.4%) respectively. Within the group of high-risk medications, Sildenafil presented higher risk of ejaculatory disorders than Tadalafil (PRR=5.85 (95%CI 5.09-6.78), P < .01). CONCLUSION: Ten drugs were recognized to display significant reporting levels of ejaculatory disorders. Among them, Finasteride and Sildenafil were responsible for the most reports in FDA-FAERS and in EV databases, respectively. Physicians should thoroughly counsel patients treated with these drugs about the risk of ejaculatory disorders. Further integration into clinical trials is needed to enhance the applicability and significance of these results. |
ジャーナル名 | Urology |
Pubmed追加日 | 2024/2/9 |
投稿者 | Nacchia, Antonio; Franco, Antonio; Cicione, Antonio; Riolo, Sara; Santoro, Giuseppe; Romagnoli, Matteo; Sarcinelli, Luca; Fiasconaro, Daniele; Ghezzo, Nicola; Gallo, Giacomo; Tema, Giorgia; Pastore, Antonio Luigi; Salhi, Yazan Al; Fuschi, Andrea; Carbone, Antonio; Franco, Giorgio; Lombardo, Riccardo; Tubaro, Andrea; De Nunzio, Cosimo |
組織名 | 'Sapienza' University of Rome, Department of Urology, Rome, Italy.;'Sapienza' University of Rome, Department of Urology, Rome, Italy. Electronic;address: cosimodenunzio@virgilio.it. |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38331221/ |